BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14676975)

  • 1. Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound.
    Koda M; Matsunaga Y; Ueki M; Maeda Y; Mimura K; Okamoto K; Hosho K; Murawaki Y
    Eur Radiol; 2004 Jun; 14(6):1100-8. PubMed ID: 14676975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
    Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.
    Mandai M; Koda M; Matono T; Nagahara T; Sugihara T; Ueki M; Ohyama K; Murawaki Y
    Br J Radiol; 2011 Jun; 84(1002):499-507. PubMed ID: 20959373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
    Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
    Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced dynamic flow imaging with contrast-enhanced ultrasonography for the evaluation of tumor vascularity in liver tumors.
    Hotta N; Tagaya T; Maeno T; Ayada M; Sato K; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
    Clin Imaging; 2005; 29(1):34-41. PubMed ID: 15859016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K
    Radiology; 2001 Aug; 220(2):349-56. PubMed ID: 11477236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma.
    Hotta N; Tagaya T; Maeno T; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
    Hepatogastroenterology; 2003; 50(54):1867-71. PubMed ID: 14696421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
    Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of arterial tumor vascularity in small hepatocellular carcinoma. Comparison between color doppler ultrasonography and radiographic imagings with contrast medium: dynamic CT, angiography, and CT hepatic arteriography.
    Furuse J; Maru Y; Yoshino M; Mera K; Sumi H; Sekiguchi R; Satake M; Hasebe T; Ochiai A
    Eur J Radiol; 2000 Oct; 36(1):20-7. PubMed ID: 10996754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
    Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL
    Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced, wide-band, phase inversion harmonic power Doppler imaging of hepatocellular carcinoma.
    Janica J; Serwatka W; Polaków J; Kordecki K; Łebkowska U; Walecki J; Dobrzycki S
    Med Sci Monit; 2004 Jun; 10 Suppl 3():32-5. PubMed ID: 16538196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.
    Numata K; Fukuda H; Miwa H; Ishii T; Moriya S; Kondo M; Nozaki A; Morimoto M; Okada M; Takebayashi S; Maeda S; Nozawa A; Nakano M; Tanaka K
    Eur J Radiol; 2014 Jan; 83(1):95-102. PubMed ID: 24176532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of intratumoral vascularity in small hepatocellular carcinoma by coded phase inversion harmonics.
    Wen YL; Zhou P; Kudo M
    Intervirology; 2004; 47(3-5):169-78. PubMed ID: 15383726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of hepatocellular carcinoma using digital subtraction imaging with the contrast agent, Levovist: comparison with helical CT, digital subtraction angiography, and US angiography.
    Yamamoto K; Shiraki K; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Hashimoto A; Shimizu A; Okuda Y; Nakano T
    Oncol Rep; 2002; 9(4):789-92. PubMed ID: 12066210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.
    Furuse J; Nagase M; Ishii H; Yoshino M
    Br J Radiol; 2003 Jun; 76(906):385-92. PubMed ID: 12814924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levovist-enhanced Doppler sonography versus spiral computed tomography to evaluate response to percutaneous ethanol injection in hepatocellular carcinoma.
    Fiore F; Vallone P; Ricchi P; Tambaro R; Daniele B; Sandomenico F; De Vivo R; Civiletti C; Izzo F; Pignata S; Ziviello M
    J Clin Gastroenterol; 2000 Sep; 31(2):164-8. PubMed ID: 10993437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma treated with chemoembolization: assessment with contrast-enhanced doppler ultrasonography.
    Catalano O; Esposito M; Lobianco R; Cusati B; Altei F; Siani A
    Cardiovasc Intervent Radiol; 1999; 22(6):486-92. PubMed ID: 10556408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
    Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
    Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.